Tethis

Tethis S.p.A, headquartered in Milan, Italy, is developing a new workflow to apply liquid biopsy to clinical practice for the precise management of cancer. Tethis' technology focuses on the standardization of blood sample preparation, providing liquid biopsy samples of the highest quality and integrity for the comprehensive analysis of all biomarkers with clinical information. The company’s proprietary nano-coated slides, combined with automated pre-analytical instruments, enable the identification and characterization of rare cells in the blood, such as circulating tumor cells, with unprecedented sensitivity in early-stage settings.